by Dispatch Risk Analysis | Feb 22, 2024 | Economic, Social, Tunisia
Tunisia: Drug Prices to Rise Slightly as Pharma Sector Struggles Summary: On 19 February 2024, officials representing the pharmaceutical industry announced price increases for 280 drugs sold in Tunisian pharmacies. These increases come as various players in the...
by Dispatch Risk Analysis | Sep 20, 2023 | Security, Social, Tunisia
Tunisia: COVID-19 Cases Emerge as Flu Season Set to Begin Summary: On 20 September 2023, the Ministry of Health announced that the seasonal flu vaccine campaign was underway, with flu season approaching. The Ministry encouraged all citizens to receive flu vaccines,...
by Dispatch Risk Analysis | Jul 13, 2023 | Economic, Social, Tunisia
Tunisia: Medicine Shortages Worsen as State Budget Strained Summary: Multiple recent reports have highlighted the ongoing challenge faced by Tunisians in accessing medicine, including reports from Reuters, The National, and the Minority Rights Group. As the economic...
by Dispatch Risk Analysis | Dec 11, 2022 | Economic, Social, Tunisia
Tunisia: Medicine Shortage Exasperated by Wholesale Distributor Strike Summary: On 5 December 2022, the Union of Wholesale Medicine Suppliers announced a labor strike. The strike was called to protest the government’s failure to respond to demands to reduce the tax...
by Dispatch Risk Analysis | Nov 11, 2022 | Economic, Social, Tunisia
Tunisia: Pharmaceutical Companies Announce Exit Summary: Three multinational pharmaceutical firms have announced plans to withdraw from Tunisia by the end of 2022 citing financial, administrative, and governance challenges. GSK, Bayer, and Novarti have announced...
